Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Embr Labs Continues Momentum as Leader in Thermal Wellness


News Image

Embr Labs, the breakthrough thermal technology company and creator of the Wave Bracelet, today announced a strategic investment by Joy Ventures and the appointment of Dr. Pamela Peeke as Embr Labs’ Chief Medical Officer. Both moves help to solidify the company’s leadership in women’s health, wellness and digital therapeutics. The state of Massachusetts and the National Science Foundation recently recognized Embr Labs’ role as a life sciences innovator by funding Artificial Intelligence for Menopause Symptoms, a collaboration between Embr Labs and UMass Institute for Applied Life Sciences that will produce the largest physiological dataset for natural menopause and advance the state of the art for detecting and predicting vasomotor symptoms, also known as hot flashes.

Dr. Pamela Peeke joins Embr Labs as Chief Medical Officer and will oversee clinical trials of the company’s cutting-edge wearable that helps to improve women’s stress, sleep and menopause symptoms. Dr. Peeke is a nationally renowned physician, scientist and expert in preventive and lifestyle medicine. She is also a Pew Foundation scholar in metabolism and a fellow of both the American College of Physicians and the American College of Sports Medicine, the latter of which she is a board member. As a three-time NY Times bestselling author and host of HER, the top women’s health show on iTunes, Apple, and RadioMD, Dr. Peeke’s message of health and wellness touches the lives of millions of women in the US and globally.

“As a physician and scientist, I am excited to be joining the Embr Labs’ team. I look forward to creating clinical research opportunities and partnerships that will further the development and validation of this groundbreaking technology. At Embr Labs, we share a profound passion to improve people’s health and wellbeing through our thermal digital technology. I’m honored and thrilled to be a part of this revolutionary new science,” noted Dr. Pamela Peeke, Embr Labs’ Chief Medical Officer.

As Embr Labs solidifies its leadership as a digital therapeutic company, the company has attracted global investors such as Joy Ventures, who are committed to advancing the growing category of consumer products for wellbeing. Joy Ventures’ investment insight reflects an understanding that today’s complex world combined with intense lifestyles has created stress, anxiety and life challenges that demand accessible and holistic solutions.

“At Joy Ventures, our mission is to counterbalance today’s challenges by advancing the science of everyday joy. We work to identify the world’s most talented entrepreneurs, innovators and scientists to evolve their ideas into products that will help us all live more joyfully – and we see Embr Labs as a company that is succeeding in this area,” noted Miri Polachek, CEO of Joy Ventures.

Started in 2013 by three MIT materials science engineers, Embr Labs was founded upon a basic insight: temperature is an untapped pathway to the brain that can deliver therapeutic benefits. Embr’s patented technology harnesses the power of thermal sensations to deliver safe, non-invasive, and beneficial therapies that leverage the body and mind’s natural response to temperature to promote relief from hot flashes, manage stress, and improve sleep.

Embr Labs has sold tens of thousands of Embr Waves that have found their way into over 160 countries despite only being available through Embr Labs’ US website. This digital thermal solution has also been clinically validated in partnership with Johnson & Johnson, and the Embr Labs’ Science and Innovation team continues to explore new ways to enhance the efficacy and impact of Embr’s technology for the nearly 1.1 billion women who will be experiencing menopause by the year 2025.

“The addition of Dr. Peeke to our leadership team and the investment from Joy Ventures, combined with our collaboration with UMass IALS and support from the Massachusetts Life Sciences Center/NSF have significantly accelerated our development and validation of innovative digital thermal solutions for women’s health,” said Elizabeth Gazda, CEO of Embr Labs.

For more information, please contact Heather Ritchie or press@embrlabs.com, or visit embrlabs.com.

About Embr Labs

Embr Labs is the first thermal wellness technology company, pioneering a new pathway to unlock the therapeutic power of temperature. Its first product, Embr Wave, is an intelligent bracelet that uses temperature to activate and balance the body and mind. Despite only being sold in the United States, the Wave is being used in over 160 countries. The company’s patented technology harnesses the power of thermal sensations to deliver a brand new category of safe, non-invasive, and natural therapies that leverage the body and mind’s natural response to temperature to help people feel more comfortable, fall asleep faster, and be less stressed. Embr Labs was founded by MIT-trained engineers and is backed by investors including DigiTx Partners, Joy Ventures, Bose Ventures and Joyance Partners.

Share article on social media or email:

Slone Partners Places John Leite as Chief Business Officer at InterVenn Biosciences


Intervenn

“John Leite is an experienced and highly accomplished business development and marketing specialist in the biotechnology and diagnostics sectors,” said Slone Partners President Tara Kochis-Stach.

Slone Partners, a nationwide executive search firm for life science, biotechnology, and diagnostics companies, has announced the placement of John Leite as Chief Business Officer at InterVenn Biosciences. In his new role, Leite will direct all business operations for the company as part of its global leadership team.

Over the past six years, Leite served as Vice President of Oncology, Market Development & Product Marketing for the oncology business unit at Illumina. Prior to joining Illumina, Leite was Vice President of Commercial Strategy and Market Access for Genoptix Inc., where, from 2008 until 2014, he drove several functions including marketing and business development, building the portfolio of oncology diagnostic services. Leite began his career as a scientist for Invitrogen (now Thermo Fisher Scientific), before transitioning to the business team as a marketer overseeing product management of the proteomics portfolio.

“John Leite is an experienced and highly accomplished business development and marketing specialist in the biotechnology and diagnostics sectors,” said Slone Partners President Tara Kochis-Stach. “He brings a keen strategic sensibility and an extremely successful track record to the InterVenn executive team.”

“We are thrilled to bring John on board at a very exciting time for our company,” said Aldo Carrascoso, Chief Executive Officer at InterVenn. “He and the rest of our global leadership team are poised to move us forward as we continue to make tremendous progress in the diagnosis and treatment of various diseases through the use of glycoproteomics.”

Leite earned his PhD in Biochemistry at the University of Pittsburgh School of Medicine. He also served his post-doc in Neuroscience at the California Institute of Technology.

ABOUT SLONE PARTNERS

Slone Partners delivers the leaders who build amazing and diverse life sciences organizations – People Are Our Science®. Founded in 2000, Slone Partners specializes in delivering world-class C-suite leadership, executive, and upper management talent to the most promising and established biotech, diagnostics, research tools, healthcare, precision medicine, CRO, and laboratory services companies. With coast-to-coast presence in the most active healthcare industry hubs of Boston, San Francisco, New York, Los Angeles, San Diego, Austin, Research Triangle Park NC, and Washington DC, Slone Partners uniquely and precisely provides an array of executive search and advisory services, including diversity, equity, and inclusion strategy, to innovative life sciences companies. To learn more about Slone Partners’ value proposition and processes, visit http://www.slonepartners.com or call 888.784.3422.

ABOUT INTERVENN BIOSCIENCES

Based in South San Francisco, InterVenn Biosciences utilizes a proprietary glycoproteomic biomarker interrogation platform using AI and mass spectrometry for next-gen precision medicine. The company is working to find new solutions in ovarian, pancreatic, liver, prostate, and kidney cancer, together with applications from the Vista suite of solutions for treatment and monitoring, immune profiling, patient stratification, and disease progression. For more information, please visit the company’s website at https://intervenn.bio/.

Share article on social media or email:

Lakeland Regional Health Makes Genomics and Personalized Medicine a Top Priority


My plan for Lakeland, in regards to genomics, is to increase utilization, customize patient treatment plans, create a sub-physician group of active platform users, and make Lakeland a leader in precision medicine that providers want to be part of.

Lakeland Regional Health is adding the ActX Genomic Decision Support platform, also known as GenoACTSM, into their electronic health record (EHR). Lakeland strives to deliver the best outcomes and safest care by placing people at the heart of all that they do. Lakeland is passionate about wellness, education, and discovery for their patients, and integrating ActX is their most recent move in creating a healthcare experience that is as personalized as possible.

Last year, leaders from Lakeland took a trip to NorthShore University HealthSystem in Chicago and were inspired by the work NorthShore has accomplished with genetics and their ActX platform integration. With ActX activated in the EHR, physicians will receive real-time alerts as they write prescriptions, and they will be able to check hereditary risks and carrier statuses, all within regular EHR workflow.

Genomics is part of the 2025 strategic vision for Lakeland. Joseph Davis, the Associate Vice President of Physician Recruitment and Ambulatory Operations, has spearheaded the ActX roll out. Davis says, “My plan for Lakeland, in regards to genomics, is to increase utilization, customize patient treatment plans, create a sub-physician group of active platform users, and make Lakeland a leader in precision medicine that providers want to be part of. I’m thrilled to be launching ActX and I can’t wait to see where it takes us”.

“We are thrilled that Lakeland has joined our effort to make genomic decision support part of regular patient care,” says Dr. Andrew Ury, ActX CEO. “Integrating our information with their EHR is crucial for making genomic support a seamless addition to Lakeland’s everyday medical care and to help to improve healthcare quality and outcomes.”

About ActX

ActX is the industry leader in EHR-integrated precision medicine. Our service helps physicians make better decisions about medical treatment, using a patient’s genetic information to guide therapy. The ActX Genomic Service offers proven, tightly integrated, real-time genomic decision support for medication orders and actionable genomic risks, a built in patient Genomic Profile, and the ability to fully customize content.

As medications are ordered, and before the prescription is finalized, medications are checked against the patient’s genetics for efficacy, adverse reactions, and dosing. Extensive evidence based and actionable content is provided as default, customizable content, covering hundreds of genes. You can easily suppress any content or interactions, or add or modify content. The ActX Genomic Service is live at numerous U.S. health systems. For more information, visit http://www.actx.com, email info@actx.com or call 888-998-2289.

Share article on social media or email:

AUO Leads to Debut High-end Surgical Display Solutions to Help Shape Future Smart Medical Care


AUO’s 32-inch 4K polarized 3D display solution is an integration of AUO’s latest 3D display technology with the advanced 2D-to-3D stereoscopic endoscopy visualization technology by MedicalTek.

Issued by: AU Optronics Corp.

Issued on: December 2, 2020

Hsinchu, Taiwan, December 2, 2020–

The integration of technology and medical care has become even closer in the post-pandemic era, and the pace of smart transformation is accelerating in the medical care industry. As part of its focus on the smart medical care sector, AUO will showcase its premium 3D surgical display solutions at the Healthcare Expo Taiwan at the Nangang Exhibition Center in Taipei from December 3 to 6. These AUO-developed solutions include the 32-inch 4K polarized 3D display solution integrated with MedicalTek’s world-leading 3D endoscope and minimally invasive surgery (MIS) visualization system, and a 15.6-inch 4K naked-eye 3D display with AUO’s proprietary eye-tracking system for use in surgery rooms. AUO also leads the industry(*) in presenting the 32-inch 4K hyper-realistic surgical display set equipped with medical-grade mini LED technology, and a range of medical panel computers designed for medical institutions in partnership with ADLINK, all demonstrating AUO’s accumulated strengths over the years to help accelerate the transformation of the medical care industry.

Expertise in High-end 3D Display Technology Taking Surgical Applications to the Next Level

AUO has years of profound experience in the development of 3D display technologies. The history goes back to the times of polarized 3D TV LCDs, large 3D interactive gaming displays, and naked-eye 3D display technologies for a variety of applications, many of which were the industry’s firsts and represented key technological milestones. Newly developed 3D display technologies are now introduced for surgical applications. The 32-inch 4K polarized 3D display solution to be exhibited represents an integration of AUO’s latest 3D display technology with the advanced 2D-to-3D stereoscopic endoscopy visualization technology developed by MedicalTek. Its use with MedicalTek’s DARWIN®3D endoscopy visualization system provides physicians with stereoscopic imagery that incorporates depth of view information. The improvement to hand-eye coordination effectively enhances the precision and quality of minimally invasive surgeries. The 15.6-inch 4K naked-eye 3D display also developed for use in surgery rooms incorporates AUO’s proprietary eye-tracking system to effectively increase the 3D field of view and image quality. Physicians can then view crystal-clear 3D imagery from different angles during surgery without wearing 3D glasses to quickly establish the relative position and depth of organs and tissues.

High-end Medical Displays with High Resolution and Mini LED Backlighting Leading the Charge

The 32-inch 4K hyper-realistic surgical display set will also be showcased for the first time at the expo. AUO’s medical-grade mini LED driver technology with the highest zone-count, along with advanced Deep Red technology for optimized display of red colors provide physicians with the most realistic colors and details. Improved distinction between minute differences in human body tissue and blood will help physicians make more accurate judgment. To meet the infection prevention and control needs in non-contact or multi-field applications in the post-pandemic era, AUO’s high resolution, low reflection and touch technologies have now been applied to a range of All-in-One (AIO) hygienically-designed medical panel computers and monitors launched by ADLINK, the global leader in industrial computers. The screwless, fanless, fully sealed aluminum housing and anti-bacterial coating on ADLINK hygienically-designed medical panel computers satisfy the highest health standards. The easy and faster cleaning and disinfection procedures help ensure the safety of patients and operators. The medical-grade touch displays have edge-to-edge glass surface and on-screen buttons that can be operated with gloved hands and are resistant to bacteria to prevent transmission of infections.

AUO is focusing on the smart medical care sector and actively investing in the development of user-centric medical-grade displays that solve the pain points of users in the field. AUO is now one of the top three global suppliers for applications such as medical-grade displays and X-ray sensors, with products extensively adopted by international medical device makers. AUO’s future strategy in the smart medical care market will focus on three areas: surgery room, medical management and medical testing. Professional display technologies will underpin the integration of pioneering AI and 5G technologies, while partnerships with customers and partners will serve to drive the smart transformation of the medical care sector. The progressive refinement of the field eco-system will enable the continued delivery of even better medical services to the general public.


  • Based on the available market research information as of December 2, 2020.

AUO photos can be downloaded at the Company’s website:

https://auo.com/en-global/Download_Photos

Any use of photographs must cite the source thereof as AU Optronics Corporation.

ABOUT AU OPTRONICS

AU Optronics Corp. (“AUO”) is one of the world’s leading providers of optoelectronic solutions. Based on its profound R&D and manufacturing experience, AUO offers a full range of display applications and smart solutions integrating software and hardware, and leverages its core expertise to enter new business areas such as solar, smart retail, general health, circular economy and smart manufacturing service. Additionally, AUO has also been named to the Dow Jones Sustainability World Index since 2010. AUO’s consolidated net revenues in 2019 were NT$268.79 billion. For more information, please visit AUO.com.

Safe Harbour Notice

AU Optronics Corp. (“AUO” or the “Company”), a global leader of TFT-LCD panels, today announced the above news. Except for statements in respect of historical matters, the statements contained in this Release include “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on our management’s expectations, projections and beliefs at the time regarding matters including, among other things, future revenues and costs, financial performance, technology changes, capacity, utilization rates, yields, process and geographical diversification, future expansion plans and business strategy. Such forward looking statements are subject to a number of known and unknown risks and uncertainties that can cause actual results to differ materially from those expressed or implied by such statements, including risks related to the flat panel display industry, the TFT-LCD market, acceptance of and demand for our products, technological and development risks, competitive factors, and other risks described in the section entitled “Risk Factors” in our Annual Report on Form 20-F filed with the United States Securities and Exchange Commission on March 27, 2020. In addition, our SEC reports, including our Annual Report on Form 20-F contains other information on these and other factors that could affect our financial results and cause actual results to differ materially from any forward-looking information we may provide. We undertake no obligation to update or revise any forward-looking statements to reflect subsequent events, new information or future circumstances.

For more information, please contact:

Corporate Communication Division

Jessie Lee    Tel: +886-3-5008800 ext 3206    Email : jessie.jc.lee@auo.com

Katie Chen    Tel: +886-3-5008800 ext 3615    Email : katie.chen@auo.com

Share article on social media or email:

Former FDA Reviewer and Investigator, Division of Manufacturing and Product Quality, CBER, Joins NDA Partners as Expert Consultant


News Image

Mr. Godshalk’s FDA and industry experience and expertise in CMC, quality, product development, manufacturing, and cGMP make him a valuable resource to our clients developing biologics, including cell and gene therapies, vaccines, and biologic devices.

NDA Partners President Earle Martin announced today that John Godshalk, MSE, MBA, a former Reviewer and Investigator in the FDA Division of Manufacturing and Product Quality in CBER, has joined the firm as an Expert Consultant. As an FDA Reviewer, he was responsible for reviewing CMC sections of BLA submissions, leading pre-approval inspections for new biologics, device, and biotechnology products, conducting meetings with industry, and developing regulatory strategies. He is an expert in CMC, quality, and facility issues for cell and gene therapies and has experience with biologics, vaccines, drugs, drug/device combinations, biologic devices, and in vitro diagnostics.

In addition to his FDA experience, Mr. Godshalk has also consulted with small to large biopharma companies on CMC, quality strategy, quality assurance, product development and manufacturing, GMP systems for the US and EU, and auditing and training. Early in his career, he was a Research Engineer at Westvaco Corp. and Pilot Plant Manager at Energy BioSystems Corp.

According to Dr. Ellen Feigal, Manager of NDA Partners’ biologics practice, “We are pleased to welcome Mr. Godshalk to NDA Partners as an Expert Consultant. His FDA and industry experience and expertise in CMC, quality, product development, manufacturing, and cGMP, make him a valuable resource to our clients developing biologics, including cell and gene therapies, vaccines, and biologic devices.”

Mr. Godshalk earned his master’s degree in chemical and biochemical engineering from Johns Hopkins University and MBA in marketing and finance from the University of Maryland, College Park and the Merrick School, University of Baltimore. He received his bachelor’s degree in chemical engineering from North Carolina State University.

About NDA Partners

NDA Partners, a part of The Planet Group, is a life sciences management consulting and contract development organization (CDO) focused on providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide. The highly experienced Principals and Expert Consultants in NDA Partners include three former FDA Center Directors; the former Chief Executive Officer and Chief Science Officer at the United States Pharmacopeial Convention (USP); an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and contract management of client product development programs.

Contact

Earle Martin, President

Office: 540-738-2550

MartinEarle@ndapartners.com

Share article on social media or email:

iaedp™ Foundation’s International Chapter Offers Virtual Training Course in All Spanish through December 31, 2020


“This is a very special and rare opportunity for healthcare professionals who need this training in Spanish from the very best in the field of eating disorders treatment,” said Blanche Williams, iaedp™ Director of International Development.

In a first from iaedp™’s International Chapter, an eating disorders treatment training course is presented in all Spanish virtually by its renowned collective of experts including Dra. Rosanna Mauro, MS, CEDRD-S, Dra. Julieta Velez-Belmonte, PsyD, CEDS, NCC-OPCA, Dra. Juanita Gempeler Rueda, MD, FAED, Dr. Rodrigo León, PsyD, Dr. Antonio Tena, PsyD, Dra. Aridia Vásquez, MD, MS, RD, Dra. Eva Trujillo, MD, F.iaedp, FAED, Dra. Zuleika Morillo, MD, and Dr. Emmett Bishop, MD, FAED, F.iaedp, CEDS.

The International Association of Eating Disorders Professionals (iaedp™) is a premiere provider of educational programs and training standards for eating disorder treatment specialists and other healthcare professionals. Its International Chapter proudly serves a global community.

“This is a very special and rare opportunity for healthcare professionals who need this training in Spanish from the very best in the field of eating disorders treatment,” said Blanche Williams, iaedp™ Director of International Development.

The cost for 11 expert sessions with two roundtable discussions is $130; students with credentials is $100; those who register with a friend is $100 each and registrants must include the name of each person in the registry. A Certificate of Participation will be awarded at completion of the training.

The training program presenters and workshops available in the course presentations include:

Brief Introduction to the Integrative Treatment of Eating Disorders – Dra. Julieta Velez-Belmonte, PsyD, CEDS, NCC-OPCA and Dra. Rosanna Mauro, MS, CEDRD-S

Functional Body: A Comprehensive and Novel Alternative to Managing Body Distortion on Eating Disorders – Dra. Juanita Gempeler Rueda, MD, FAED

Eating Disorders Prevention Model Based on Risk Level – Dr. Rodrigo León PsyD

Study and Clinical Practice of Binge Eating Disorder, Proposals Towards Its Comprehensive Care – Dr. Antonio Tena, PsyD

Beyond Food: Integrative Nutrition Therapy for Eating Disorders – Dra. Aridia Vásquez, MD, MS, RD

Eating Disorders from a Preventive Medical Perspective – Dra. Eva Trujillo, MD, F.iaedp, FAED

Roundtable- Feeding Disorders, Pica, Rumination Disorder – Dra. Aridia Vásquez, MD, MS, RD; Dra. Julieta Vélez-Belmonte, PsyD, CEDS, NBCC-OPCA; Dra. Zuleika Morillo, MD; Dra. Juanita Gempeler Rueda MD, FAED

From Theory to Practice: Role of the Psychiatrist in Eating Disorders – Dra. Zuleika Murillo, MD

ACT as a Strategy for Managing Personality Traits in Patients with Eating Disorders – Dr. Emmett Bishop, MD, FAED, F.iaedp, CEDS

Psychological Aspects of Eating Disorders and Body Image – Dra. Julieta Vélez-Belmonte, PsyD, CEDS, NBCC-OPCA

Reconstructing Eating Identity in Eating Disorders: A Key Factor for Recovery – Dra. Rosanna Mauro, MS, CEDRD-S, NBC-HWC

Round Table: ARFID – Dr. Emmett Bishop, Dra. Eva Trujillo, Dra. Rosanna Mauro.

REGISTRATION: https://iaedp.site-ym.com/event/ElCuerpoTerritorioDeLaImagen

Learn more about our International Chapter:

https://membershare.iaedp.com/international-chapter/

https://membershare.iaedp.com/international-chapter/en-espanol/

About the iaedp™ Foundation: Since 1985, the International Association of Eating Disorders Professionals has provided education and training standards to an international and multidisciplinary group of various healthcare treatment providers and helping professions. MemberSHARE.iaedp.com is an iaedp™ business journal and online member resource to learn about noteworthy member achievements, continuing education webinars and U.S. and International Chapter activity and events; for more information, visit MemberSHARE.

Share article on social media or email:

HIPAA-compliant Email Security Stops Ransomware Attacks on Hospitals


Healthcare networks are targeted by ransomware, says FBI

Relying on staff to protect network security is dangerous

“HIPAA-compliant security must meet stringent standards for email handling, including legitimate encryption” –MailRoute CEO Tom Johnson

On October 29, 2020, the Cybersecurity and Infrastructure Security Agency (CISA), the Federal Bureau of Investigation (FBI) and the U.S. Department of Health and Human Services (HHS) warned of an increased, imminent threat to U.S. hospitals and healthcare providers.

The agencies have credible information that malicious cyber actors are targeting the healthcare and public health sectors with malware that can result in ransomware attacks, disruption of healthcare services and data theft.

Protective measures to prevent ransomware attacks often include alerting employees to be vigilant with respect to phishing attempts. This “people-centric approach” touted by most data security services is simply a way of saying the onus is on the end-user. This appears to be an abdication of responsibility by paid services who are employed to protect their clients. When reassessing an entity’s essential cyber incident response plan, it is imperative to include a HIPAA-compliant gateway security service.

To protect clinicians and patients from targeted threats and ensure data is HIPAA compliant requires a gateway security service, which sits outside the network and functions as the first, and most stringent, line of defense against malicious attacks.

“These targeted ransomware attacks are being waged on hospitals and healthcare facilities because those entities retain data valuable to bad actors as well as the monetary gain from paid ransom,” explains MailRoute founder and CEO Thomas Johnson.

“Finding a HIPAA-compliant security service is difficult, because they must meet the stringent standards of the Federal government as relates to email handling, including legitimate encryption and storage timeframes on a vendor’s network.

“Companies that focus on myriad data services often cannot meet these standards, since they use third-party encryption services that are less robust than required. MailRoute focuses on a core competency of email security, so we are compliant on all levels,” Johnson concludes.

A gateway service eliminates heightened security risks, should have API-level integration and should work with all email platforms and servers. MailRoute’s cloud-based email filtering solution, for example, stops unwanted inbound emails and potential attacks before they ever reach mail servers. Outbound monitoring also blocks confidential files from leaving a client’s network.

Cyber Threat Protection

Virtual healthcare is becoming the new normal with the continual increase in the use of web-based mobile apps between doctors and patients and the resulting electronic health records stored in a virtual black hole. Because medical records contain the most lucrative data for hackers to sell on the black market, cyber-attacks on healthcare systems continue to grow.

Email Compliance

While it is critical that hospitals and healthcare facilities meet HIPAA compliance regulations, it’s also important to streamline compliance and regulatory processes for IT teams by using a reliable, efficient and secure gateway service to stop malware, ransomware, phishing attacks, and other spam and viruses.

The joint CISA, FBI and HHS alert (AA20-302A) can be found here.

Share article on social media or email:

Allergy Partners Discussed Holiday Allergy Season and How to Prepare for Them


As the weather turns cold and the calendar moves from Thanksgiving, the Holiday season is just around the corner. While this year’s festivities will be smaller than usual, we will soon start to retrieve the decorations from the attic and to plan for the big cookie bake. While certainly my favorite time of the year, the Holidays and present challenges for allergy sufferers.

1. Foods: Cakes, cookies, candies and sweets are just part of holiday fun. For those with food allergies, hidden ingredients like nuts or dairy. Perhaps more than any time of the year, its important for those with food allergies to always ask about ingredients before taking a bite. If the host is not sure, it’s best to politely decline!

2. Christmas trees: Allergic to Christmas trees?!? Trees may have mold spores that can trigger allergies and asthma, while artificial trees can carry dust after prolonged storage. It may be a good idea to air out the tree in a dry place like the garage before bringing it inside.

3. All those ornaments: Boxes and boxes of decorations are in my attic and, try as we might, the things get dusty. When moving boxes, wear a mask and clean off dusty items outside or in a well-ventilated area.

4. Candles: Almost as important as the sights of the season are the smells. For some people, however, strong scents and perfumes can trigger sneezing, runny nose and even asthma symptoms.

5. Pets: When visiting friends and relatives, it’s a good idea to find out who has pets and who is pet allergic. It’s always a good idea to take extra precautions such as keeping pets outside, taking an antihistamine before arriving, and being sure to have your rescue inhaler.

Most importantly, don’t let the Allergy Grinch steal your Holiday fun. Taking some time to spot potential problems upfront and being prepared can help make the Holidays happy for everyone.

Allergy Partners, PLLC is the nation’s largest single specialty practice with multiple locations across the United States. Our allergists provide evaluation and treatment of following conditions:

Allergic Rhinitis | Asthma | Food Allergies | Eczema Hives | Sinus Problems | Stinging Insect Allergies | Immune Deficiencies | Chronic Cough | Drug Allergies Recurrent Infections | Eosinophilic Esophagitis | Allergist | Pediatric Allergist

Share article on social media or email:

A Tale of Two Systems Webinar Dec. 17, 2020


WCG FDAnews

WCG FDAnews

Adverse Event Reporting:

A Tale of Two Systems

An FDAnews Webinar

Thursday, Dec. 17, 2020, 1:30 p.m.-3:00 p.m. EST

https://www.fdanews.com/aereporting

Reporting an adverse event in the U.S.? If a device is being marketed in the EU, one must report it there as well. And there are different requirements in the two regions making the task even more complicated.

During this Adverse Event Reporting: A Tale of Two Systems webinar on Dec. 17, attendees will find ways to make the process more straightforward. Through Ombu Enterprise’s regulatory reporting paradigm, one will learn the similarities and differences between the two systems when it comes to triggers, timing, content, transmission, retention, custodian and access. Get practical insights into the process and discover what methods a team should use to ensure compliance.

Dan O’Leary, President of Ombu Enterprises, will demonstrate these procedures with a hypothetical event that would be reportable in the U.S. and the EU. One will move through both forms with a side-by-side analysis of the obligations and steps, gaining the insights needed to complete a successful reporting document.

During this webinar, attendees will cover:

  • Key requirements in adverse event reporting to regulators in the U.S. and the EU
  • Important differences between reporting systems in both regions
  • Recent changes in the adverse event reporting forms in the U.S. and the EU
  • Comparisons of the content expectations in the forms for both systems
  • The details of a report, including what triggers it, how much time a manufacturer has to report, what is included on the forms, how to share this information with a regulator, how long the report should be kept, who is responsible for reporting and who has access to the report

Adverse event reporting is never a simple process but having to do it in two places makes it twice as complicated. Join this webinar and get the knowledge you need to more smoothly and appropriately report an event in both the U.S. and the EU.

Interested in registering multiple sites?

Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally

to learn about our special multisite discount.

Webinar Details:

Adverse Event Reporting:

A Tale of Two Systems

An FDAnews Webinar

Thursday, Dec. 17, 2020, 1:30 p.m.-3:00 p.m. EST

https://www.fdanews.com/aereporting

Tuition:

$287 per site

Easy Ways to Register:

Online: https://www.fdanews.com/aereporting

By phone: 888.838.5578 or 703.538.7600

About FDAnews:

FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews’ print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations

Share article on social media or email:

Crunch Fitness has Chosen MatrixPoint Consulting to Manage their Data Privacy Initiative


MatrixPoint Consulting

We are excited to work with MatrixPoint and help show our members that we truly care about their safety and privacy

MatrixPoint Consulting, a data-centric consulting firm specializing in marketing efficiency and data privacy compliance, announced today that it has been selected as the data privacy consulting firm for Crunch Fitness, the gym known for making serious fitness fun and fostering a culture of ‘No Judgments’. MatrixPoint will be the lead consulting firm for Crunch Fitness and will provide ongoing data privacy solutions and support to ensure Crunch Fitness is compliant with US regulations.

“We are excited to work with MatrixPoint and help show our members that we truly care about their safety and privacy,” said Chad Waetzig, EVP of Marketing and Branding, Crunch Fitness. “This partnership is part of our ongoing commitment to create long-term trust with our members and ensure we continue earning their well-placed trust.”

“Companies must prepare for the increasingly complex and evolving data privacy and security regulations,” said MatrixPoint Managing Partner, Brian Mahoney. “Our significant experience, coupled with our innovative approach in protecting and unlocking data, positions us perfectly to support the data privacy needs of Crunch Fitness.”

The Crunch Fitness business will be managed out of the MatrixPoint offices located in Irvine and Denver. For more information regarding the MatrixPoint-Crunch Fitness relationship, please contact Stacy Smith, Marketing Manager for MatrixPoint Consulting.

ABOUT MATRIXPOINT

MatrixPoint Consulting is a data-centric consulting firm that specializes in marketing efficiency, data privacy compliance, and Machine Learning (ML) processing. The firm helps companies improve their business processes, their relationship with their customers, and ultimately, their bottom line.

ABOUT CRUNCH

Crunch is a gym that believes in making serious exercise fun by fusing fitness and entertainment and pioneering a philosophy of ‘No Judgments.’ Crunch serves a fitness community for all types of people, with all types of goals, exercising all different ways; working it out at the same place together. Today, Crunch is renowned for creating one-of-a-kind group fitness classes, high-intensity interval training (HIIT) classes, and unique programming for a wildly diverse membership. Headquartered in New York City, Crunch serves over 1,300,000 members with over 300 gyms worldwide in 29 states, Puerto Rico, and 4 countries. Crunch is rapidly expanding across the U.S. and around the globe. For more information, please visit crunch.com.

Share article on social media or email: